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INTRODUCTION
Pulmonary adenocarcinoma is a common malignancy that
is prone to calcification, although bone formation in prima-
ry lung adenocarcinoma is extremely rare. Heterotopic ossi-
fication in primary lung adenocarcinoma was first described
by McLendon et al. in 1985 (1). To our knowledge, howev-
er, only 11 cases of pulmonary adenocarcinoma with hetero-
topic ossification have been reported in the literature, and
the isolated cases described in these reports involved ossifi-
cation in bronchogenic carcinoma (1-11). Thus, the mecha-
nism of heterotopic ossification in pulmonary adenocarcino-
ma is unknown. 
Here, we describe the clinicopathologic features of ten cases
of pulmonary adenocarcinoma with heterotopic ossification
in addition to a review of previously published data and a di-
scussion on the histogenesis of bone formation.
MATERIALS AND METHODS 
Ten cases of pulmonary adenocarcinoma with heterotopic
ossification diagnosed in the Department of Pathology at the
Samsung Medical Center in Seoul, Korea, between 2003 and
2007 were considered (Table 1). The surgical procedures per-
formed on the patients included nine lobectomies and one
bilobectomy. All tumors less than 5 cm were completely em-
bedded in paraffin. Hematoxylin and eosin (H&E)-stained
slides were then prepared for analysis by two experienced pul-
monary pathologists to confirm the diagnosis and to assess
multiple histologic features. Each patient’s medical records
and surgical pathology reports were also reviewed. Immuno-
histochemical staining was performed in patients 1-8 using
4-μ m-thick tissue sections and a Bond Polymer Intense Detec-
tion System (VisionBioSystems, VIC, Australia) according to
the manufacturer’s instructions with minor modifications. In
brief, each formalin-fixed and paraffin-embedded section was
deparaffinized with Bond Dewax Solution (VisionBioSys-
tems), and subjected to antigen retrieval using Bond ER Solu-
tion (VisionBioSystems) at 100℃ for 30 min. The endoge-
nous peroxidase was subsequently quenched by incubation
with hydrogen peroxide for 5 min. The sections were then
incubated for 15 min at room temperate with thyroid tran-
scription factor-1 (TTF-1) (8G7G3/1; 1:3,000; Dako, Glo-
strup, Denmark), p53 (DO-7; 1:1,000; Novocastra, New-
castle Upon Tyne, U.K.), Ki-67 (MIB-1; 1:500; Dako), osteo-
pontin (OP3N; 1:400; Novocastra), osteocalcin (FL-100; 1:
50; Santa Cruz Biotechnology, Santa Cruz, CA, U.S.A.), Ru-
nx-2 (1D2; 1: 1,000; ABNOVA, Taipei, Taiwan) and trans-
forming growth factor-β 1 (TGF-β 1) (rabbit polyclonal; 1:25;
NeoMarkers, Fremont, CA, U.S.A.) using a biotin-free poly-
meric horseradish peroxidase-linker antibody conjugate sys-
tem in a Bond-max automatic slide stainer (VisionBioSys-
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Pulmonary Adenocarcinoma with Heterotopic Ossification
Pulmonary adenocarcinoma is a common malignancy that often involves calcifica-
tion; however, bone formation in primary lung adenocarcinoma is extremely rare. In
ten cases of primary pulmonary adenocarcinoma with heterotopic ossification, we
detected immunoreactivity against TGF-β 1, osteopontin, osteocalcin and Runx2 in
the fibroblastic stroma and tumor cells within the area of ossification. Our results
suggest that in primary pulmonary adenocarcinoma, heterotopic ossification occurs
via intramembranous bone formation. To our knowledge, only 11 other cases of pul-
monary adenocarcinoma with heterotopic ossification have been reported. Here, we
present ten cases of pulmonary adenocarcinoma showing heterotopic ossification
with a description of previously published results and the histogenesis of heterotopic
bone formation.
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solution (1 mM DAB, 50 mM Tris-HCl, pH 7.6, and 0.006
% H2O2). The slides were counterstained with hematoxylin.
Formalin-fixed paraffin-embedded human gallbladder tis-
sue for osteopontin, kidney for osteocalcin, and placenta for
Runx2 and TGF-β 1 were used as positive controls. The inten-
sity of cytoplasmic staining for osteopontin, osteocalcin and
TGF-β 1 and nuclear staining for Runx2 was scored as fol-
lows; 0 (negative), + (weak), 2+ (moderate), and 3+ (strong).
The signal was also regarded as positive for osteopontin, osteo-
calcin, Runx2, TGF- β 1, TTF-1, and p53 if more than 10%
of the specific cell population was immunostained. The Ki-
67 labeled index values are given as percentages (%).
Statistical analysis
Chi-square and Fisher exact tests were used to evaluate the
association between the expression of TGF-β 1, osteopontin,
osteocalcin and Runx2 for each the tumor and the fibroblas-
tic stroma. Statistical significance in this study was consid-
ered at P<0.05. All reported p values were 2-sided. All anal-
yses were performed with SPSS software (version 15.00, SPSS,
Chicago, IL, U.S.A.).
RESULTS
The clinical features of ten cases of pulmonary adenocarci-
noma with heterotopic ossification are listed in Table 1. The
age of the patients ranged from 57 to 70 yr (mean 62.4 yr),
and the male:female ratio was 4:6. Eight patients were non-
smokers, while the remaining two (patients 2 and 5) had
stopped smoking 10 and 15 yr earlier, respectively. The ini-
tial chief complaints of the patients were largely asymptomat-
ic. Radiologically, radiopaque shadows in the center of the
lung mass indicating calcification or ossification were found
in nine of ten patients (all except patient 1). Due to the high
mineral densities observed in some of the cases, hamartoma
or tuberculosis was suspected. A trabecular pattern was ob-
served in the center of the lung mass in patient 2, suggest-
ing intratumoral ossification (Fig. 1). Nine of the patients
received lobectomies while patient 2 received a bilobectomy,
including right upper and middle lobes with dissection of the
mediastinal lymph nodes. Neoadjuvant chemotherapy and
concurrent chemoradiotherapy were administered in patient
6 and 7, respectively, while adjuvant chemotherapy was admin-
istered in patient 9.
Our pathologic findings for each of the ten patients are listed
YA, years ago; Rt, right; Lt, Left; Pph, peripheral; Cent, central; Lob, lobectomy; CT, chemotherapy; RT, radiation therapy; CCRT, concurrent chemora-
diation therapy; F/U, follow up; Mo, months.
Patients 1 2 3 4 5 6 7 8 9 10
Sex/Age F/65 M/70 M/63 F/65 M/57 F/66 F/57 F/57 M/59 F/64
Smoking No Stop 10 YA No No Stop 15 YA No No No No No
Location Rt S1 Rt S4 Rt S2 Rt S8 Lt S9 Rt S3 Lt S6 Lt S9 Rt S3 Rt S10
Pph/Cent Pph Cent Pph Pph Pph Cent Pph Pph Pph Pph
Operation Lob Bilob Lob Lob Lob Lob Lob Lob Lob Lob
CT/RT No CT after CT after No No Neoadjuvant Neoadjuvant No Adjuvant No
recur recur CT CCRT CT
Recur No after 16 Mo after 30 Mo No No No No No No No
F/U (Mo) Alive (52) Alive (49) Alive (43) Alive (27) Alive (14) Alive (13) Alive (12) Alive (10) Alive (4) Alive (4)
Table 1. Clinical features of pulmonary adenocarcinoma with heterotopic ossification
Fig. 1. Chest CT showing a radiodense trabecular pattern (arrow)
in the center of the lung mass (patient 2).
Fig. 2. Bone formation in the adenocarcinoma (H&E staining, ×1).506 G.Y. Kim, J. Kim, T.S. Kim, et al.
in Table 2. The tumor, which initially appeared to be solid
gray-white solid masses, had a granular appearance during
sectioning, indicating calcification or ossification. The tumors,
which ranged in diameter from 2 to 7 cm (mean 3.8 cm), were
located in the right upper lobe in four patients, the left lower
lobe in three patients, the right lower lobe in two patients,
and in the right middle lobe in one patient. Histologically,
the tumor pattern was papillary-tubular in eight patients, pap-
illary in one patient (patient 3), and solid-tubular pattern in
one patient (patient 6). The tumors were moderately differ-
entiated in all cases except case 6, which exhibited poor dif-
ferentiation. Mitotic figures were frequently observed in the
tumor cells, and all of the tumors contained fragments of os-
seous tissue within the abundant central fibroblastic stroma
(Fig. 2). Dense connective tissue was present in the area of
ossification, but was absent from the periphery of the cancer
(where ossification was not observed). In patient 8, occasional
psammoma bodies were observed in the tumor papillae. Cel-
lular atypia was absent from the stromal fibroblastic cells,
osteoblasts, and osteocytes (Fig. 3). Minimal tumor necrosis
(<5% of the tumor area) was present in patients 2, 6, 7, and
8; however, no necrosis was found in the ossification area. In
patient 1, chronic inflammation was detected in the fibrob-
lastic stroma; however, none of the other patients exhibited
a mucin pool, inflammation, or preexisting calcification of
the fibrous stroma in the area of ossification. Hyaline cartilage
T, tubular; P, papillary; S, solid; Md, moderate, Pr, poor; PLM, polarizing light microscopy; LN, lymph node.
Patients 1 2 3 4 5 6 7 8 9 10
Tumor size (cm) 3.2 4 3.7 6 4.5 2 7 2.5 2.5 2.8
Pattern T/P P/T P T/P P/T S/T P/T T/P T/P P/T
Differentiation Md Md Md Md Md Pr Md Md Md Md
Ossification size (cm) 0.05 2 0.4 1.3 1.5 0.3 0.6 0.9 0.2 0.6
Osteoid formation - ++ + +++ + - +
Osteoblastic rimming + + + + + + + + + +
Bone marrow - + - ++- + - ++
Lamination (under PLM) + + - ++ + +++ +
Osteoclasts - + - ++ +- + --
Ossification in fibroblastic stroma + + + + + + + + + +
Ossification in necrosis ----------
Ossification in mucin pool ----------
Inflammation in fibroblastic stroma + --- ---- --
Preexisting calcification ----------
Psammoma body in tumor -------+ --
Cartilage formation ----------
Tumor necrosis (%) 0 5 0 0 0 5 5 5 0 0
Osteoplastic metastasis in LN . No . . . No No . . .
Pathologic TNM  200 210 200 200 200 110 220 100 400 200
Patholgic stage IB IIB IB IB IB IIA IIIA IA IIIB IB
Table 2. Pathologic findings of pulmonary adenocarcinoma with heterotopic ossification
Fig. 3. (A) Microscopic images showing moderately differentiated adenocarcinomas with mature bony trabeculae in the abundant fibrob-
lastic stroma. (B) Microscopic images showing spindled fibroblastic cells and bony trabeculae with osteoblastic rimming and osteocytes.
Cellular atypia is absent (H&E staining, [A] ×40; [B] ×200).
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formation and a bluish chondroid stroma were absent in all
patients. The size of the ossification area ranged from 0.05 to
2 cm (mean 0.78 cm). A tiny bony trabecula measuring 0.05
cm in length was observed in patient 1. Within the osseous
tissue, osteoid formation with calcification and fully mature
trabecular bone having osteocytes, osteoblastic rimming, and
lamellation were observed. Lamellation of the trabecular bone
under polarizing light was observed in eight of ten patients
(Fig. 4), while rows of osteoblasts were seen along the edge of
the osseous trabeculae, in all ten patients. Evident marrow
spaces were observed in six of ten patients, while osteoclastic
activity suggesting bone remodeling was found in five of ten
patients. Metastasis of the peribronchial lymph nodes (N1 nodal
stage) in patients 2 and 6, and the mediastinal (N2) lymph
nodes in patient 7 was present, but bone formation was not
detected.
Our immunohistochemistry are listed in Table 3. The tumor
and fibroblastic stromal cells reacted with antibodies against
TGF-β 1, osteopontin, osteocalcin and Runx2 (Fig. 5A, D).
The intensity of TGF-β 1 and Runx2 staining was the same
in the tumor and fibroblastic stromal cells. The immunore-
activity against osteopontin and osteocalcin was the stronger
in the tumor and the fibroblastic stromal cells, respectively.
The intensity of osteopontin was more significantly strong in
the fibroblastic stroma of ossification area compared to the
non-ossification (P=0.029). However, there was no significant
difference in those of osteocalcin (P=0.097). The tumor cells
also reacted with TTF-1 in all cases. Positive collagen type
IV immunostaining was observed in patient 3 in the fibrob-
Fig. 4. Polarizing light microscopy showing lamellation of the tra-
becular bone (H&E staining, ×200).
Fig. 5. Immunohistochemical staining showing the presence of osteopontin (A), TGF-β 1 (B), osteocalcin (C), and Runx2 (D) in the tumor
and fibroblastic stromal cells. Polymer method, ×200.
A B
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lastic stromal cells. Positive reactivity for p53 was observed
in six of eight patients (75%), and the index of positivity in
the tumor cells ranged from 30 to 90% (mean 55.8%). The
Ki-67 labeled proliferating index value for the tumor cells
ranged from 1 to 35% (mean 11.3%); however, in the fibrob-
lastic stromal cells, the index value was 0% in all cases. 
All ten patients were alive during the follow-up period (4-
52 months, mean 22.8 months). Two patients (patients 2 and
3) had recurrent remnants in the right lower lobe and at the
lobectomy stump area 16 and 30 months after surgery, respec-
tively, and chemotherapy was administered.
DISCUSSION
Intratumoral calcification has been observed in various neo-
plasms. In fact, benign heterotopic bone formation within
neoplasms has been sporadically reported in the kidney, liver,
gastrointestinal tract, breast, thyroid, skin, and soft tissues.
In contrast to dystrophic calcification, which frequently occurs
in necrotic areas of cancer, heterotopic ossification within pri-
mary lung carcinomas is extremely rare. Although bronchial
carcinoid is one such calcifying or ossifying tumor, a review
of the literature revealed only 11 other cases of heterotopic
ossification in pulmonary adenocarcinoma and two cases in
pulmonary squamous cell carcinoma (1-13). All previously
published cases of pulmonary adenocarcinoma with hetero-
topic ossification are listed in Table 4. In those cases, the pa-
tients ranged in age from 49 to 76 (mean 62.5 yr) and the
male:female ratio was 7:4. One of the 11 patients was Am-
erican, while the others were Japanese. The predominant his-
tologic type of the tumors was moderately differentiated ade-
nocarcinoma with a dense fibrous stroma located at the periph-
., no data.
YA, years ago; Mo, months; Rt, right; Lt, left; RLL, right lower lobe; LUL, left upper lobe; LLL, left lower lobe; Lob, lobectomy; Cent, central; Pph, periph-
eral; T, tubular; P, papillary; CT, chemotherapy; RT, radiation therapy; T, tubular; P, papillary; Mod, moderate.
Author McLendon Yoshida Miyata Fukuse Hayakawa Tsuchiya Hara Hosoda Usami Ueshima Kato
year (Ref No.) 1985 (1) 1988 (2) 1998 (3) 1990 (4) 1997 (5) 2000 (6) 2000 (7) 2002 (8) 2005 (9) 2005 (10) 2006 (11)
Sex/age M/62 M/49 F/62 M/61 M/53 F/70 F/70 M/66 M/46 F/73 M/76
Nation American Japanese Japanese Japanese Japanese Japanese Japanese Japanese Japanese Japanese Japanese
Smoking Yes No No Stop 20 YA Yes . No No . . No
Symptoms Chest pain Cough No Cough Lumbago No Cough, No No No No
hemoptysis
Follow up . Recur, . . Dead, . alive, . Alive, . .
60 Mo 33 Mo 6 Mo 14 Mo
CT/RT . . . . RT . . . . . .
Location RLL Rt. S6 Rt. S2 Lt. S8 LUL Lt. S3a Lt. S10 Rt. S10 LUL LLL Rt. S2
Procedure Lob Lob Lob Lob Autopsy Lob Lob Lob Lob Lob Lob
Pph/cent Cent Pph Pph Pph Pph Pph Pph Pph Cent . Pph
Tumor (cm) 3 3.5 3.3 4.5 . . 3.2 3 4.5 . 1.5
Pattern T/P T P P T P T T/P T P/T P
Differentiation Mod Mod Well Mod Mod . Mod Mod Poor . .
Osteoplastic - +. .+.- ....
metastasis
Bone marrow . - ...+- ...+
Stage IIIA IIB IB IB IV IA IIIB IA IB . IA
T1 2 2 2 . 1 4 1 2 . 1
N 210020200. 0
M 000010000. 0
Table 4. Previously reported cases of primary pulmonary adenocarcinoma with heterotopic ossification
*Statistically significant.
Tumor (%) Fibroblastic stroma (%)
Ossification Non-ossifi- Ossification Non-ossifi-
area cation area area cation area
TGF-β 1 1+ 7 (87.5) 7 (87.5) 7 (87.5) 7 (87.5)
(n=8) 2+ 1 (12.5) 1 (12.5) 1 (12.5) 1 (12.5)
P 1.000 1.000
Osteopontin 1+ 0 (0) 0 (0) 3 (37.5) 8 (100)
(n=8) 2+ 4 (50) 4 (50) 4 (50) 0 (0)
3+ 4 (50) 4 (50) 1 (12.5) 0 (0)
P 1.000 0.029*
Osteocalcin 1+ 6 (75) 6 (75) 2 (25.5) 6 (75)
(n=8) 2+ 1 (12.5) 1 (12.5) 5 (62.5) 1 (12.5)
3+ 1 (12.5) 1 (12.5) 1 (12.5) 1 (12.5)
P 1.000 0.097
Runx2 (n=8) 2+ 3 (37.5) 3 (37.5) 3 (37.5) 3 (37.5)
3+ 5 (62.5) 5 (62.5) 5 (62.5) 5 (62.5)
P 1.000 1.000
Table 3. Immunohistochemical results of pulmonary adenocar-
cinoma with heterotopic ossification (patients 1-8)Pulmonary Adenocarcinoma with Heterotopic Ossification 509
eral lung zone with pleural dimpling. Two patients also sh-
owed osteoplastic metastasis (2, 5).
Although intrapulmonary calcification is frequently observed
radiologically, distinguishing calcification from ossification is
difficult. In some cases in our series, the lesion was interpreted
as benign with hamartoma or tuberculosis. However, ossifica-
tion can be differentiated radiologically from calcification when
a trabecular or reticular pattern is detected by CT (14, 15).
Pathologic calcification implies abnormal deposition of cal-
cium salts. This is a common process that occurs under a vari-
ety of pathologic conditions, such as hypercalcemia, necrosis,
extracellular mucin and chronic inflammation. In contrast,
ossification is a more complex process involving osteoblasts
and osteocytes. Several theories exist regarding the mechanism
of intratumoral calcification and ossification, including cal-
cification in the presence of degenerative or necrotic tissues
(dystrophic calcification), entrapment of preexisting calcified
scar tissue or granulomatous disease, and calcium deposition
within the tumor as a result of mucus production by tumor
cells (16, 17).
Two means of osteogenesis are known: intramembranous
bone formation and endochondral bone formation. Both pro-
cesses feature the transformation of a primary trabecular net-
work into mature bone, but differ in terms of the starting point.
Intramembranous bone formation involves the transforma-
tion of a mesenchymal template into bone, while endochon-
dral ossification involves the replacement of a preexisting hya-
line cartilage template into bone. The sequence of events in
intramembranous bone formation includes the formation of
mesenchymal condensations via a process controlled by Wnt,
hedgehog, fibroblast growth factor, and TGF-βfamily poly-
peptides; differentiation of the mesenchymal cells into osteo-
blasts, deposition of the bone matrix by the osteoblasts, min-
eralization and differentiation of osteocytes by interstitial gro-
wth under the control of the transcription factors Cbfa1/Runx2
and osterix. Cbfa1/Runx2 is the earliest and more specific indi-
cator of osteogenesis and its expression is induced by bone
morphogenic protein 7, followed by the expression of osteo-
calcin and osteopontin. Osteopontin and osteocalcin are non-
collagenous multifunctional glycoproteins routinely found
in mineralized tissue, where it is believed to play an integral
role in the cellular response to mechanical stimuli. These pro-
teins also play a role in the initial formation of the matrix, de-
pending on the mode of ossification and bone morphogene-
sis (18, 19). A progressive increase in the amount of osteopon-
tin in the membranous bone matrix during the maturation of
new bone was previously reported (20). Osteocalcin is a spe-
cific secretory protein expressed only in terminally differen-
tiated osteoblasts under the control of Cbfa1/Runx2.
Our Immunohistochemical results provide pertinent infor-
mation concerning the histogenesis of heterotopic ossification.
We propose that the heterotopic ossification of primary pul-
monary adenocarcinomas occurs via intramembranous bone
formation, and is induced by the tumor cells. Our reasoning
is as follows; no necrosis, mucin pool, or inflammation of the
fibroblastic stroma in the area of ossification was observed in
any of the patients, except patient 1, who exhibited chronic
inflammation of the fibroblastic stroma; preexisting calcifica-
tion with hyaline cartilage formation or a bluish chondroid
stroma was not observed in the areas of ossification; the level
of immunoreactivity against TGF-β 1, osteopontin, osteocal-
cin and Runx2 was highest in the tumor cells and the fibrob-
lastic stroma; and osteopontin was more expressed in fibrob-
latic stroma surrounding the area of ossification compared to
the area of non-ossification, which indicate osteopontin has
more osteoblastic activity in fibroblastic stroma surrounding
the area of bony trabecullae. Still, we cannot completely ex-
clude the effect of the neoadjuvant chemotherapy applied to
patient 6 and neoadjuvant concurrent chemoradiotherapy to
patient 7, and patient 1 exhibited chronic inflammation of
the fibroblastic stroma and a tiny bony trabecula. However,
none of the other patients showed necrosis with cholesterol
granuloma or inflammation, the aggregation of foamy mac-
rophages, in the area of ossification.
The stromal response should be differentiated from true
sarcomatous participation in the tumors. Pulmonary carci-
nosarcomas show a distinct malignant stroma and osteoid
formation. As far as the present tumors are concerned, the
possibility of a carcinosarcoma is ruled out by the lack of malig-
nancy in the fibroblastic stroma and osteoid. The observed
intratumoral ossification consisted of fully matured bone ele-
ments with no cellular atypia, and mitosis was not detected
in the stromal fibroblastic cells. Additionally, the Ki-67 labeled
proliferating index value was 0% in the stromal fibroblastic
cells and bony trabeculae. Therefore, we presume that the
osseous elements were produced through benign reactive or
metaplastic processes.
In conclusion, we characterized ten cases of primary pul-
monary adenocarcinoma with heterotopic ossification. Alt-
hough, distinguishing calcification from ossification radio-
logically is difficult, ossification can be recognized based on
the presence of a trabecular or reticular pattern. We detect-
ed immunoreactivity against TGF-β 1, osteopontin, osteo-
calcin and Runx2 in the tumor cells and fibroblastic stroma
surrounding the area of ossification. Our results indicate that
heterotopic ossification in primary pulmonary adenocarcino-
ma occurs via an intramembranous bone formation and osteo-
pontin has more osteoblastic activity in fibroblastic stroma
surrounding the area of bony trabecullae. However, addition-
al studies with a greater number of cases are needed to elu-
cidate the mechanisms of intratumoral osteogenesis and os-
teogenic metastasis and their prognosis.
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